AWB(AI with BioTech) uses data from preclinical and clinical studies to model a drug’s effect on patients and predict whether it will be successful or not at treating a specific disease. The company has worked on a wide range of indications including liver disease, respiratory disease, hepatitis, immuno-oncology, and cardiovascular disease. Compared to other similar companies, AWB is able to work with small and large data sets alike. The AI platform is also designed to be transparent and allow users to check if the tool is working correctly.
